Targeted Beta Therapy

Targeted Beta Therapy is a targeted radiopharmaceutical therapy that selectively delivers beta-emitting radionuclides to cancer cells via molecular vectors, enabling localized irradiation while minimizing damage to surrounding healthy tissue.

13

Publications

659

Citations

72

Authors

41

Institutions

Publications per year

2017–2026

7

Variants

Targeted Beta-particle Therapy

Authors

72

  1. CC
    Colleen C. Nelson

    Queensland University of Technology, Australia

    1 publications · 25 citations

    1

    h-index

  2. AO
    Aline Oliveira da Silva de Barros

    Nuclear Engineering Institute, Brazil

    1 publications · 15 citations

    1

    h-index

  3. TS
    Thomas Sounalet

    Centre National de la Recherche Scientifique, France

    1 publications · 25 citations

    1

    h-index

  4. DH
    Douglas Houghton Campbell

    Stanford University, United States

    1 publications · 25 citations

    1

    h-index

  5. LD
    Liran Domachevsky

    Tel Aviv University, Israel

    1 publications · 20 citations

    1

    h-index

1–5 of 72

Venues

  1. 1

    h-index

  2. Frontiers in Medicine

    1 publications · 25 citations

    1

    h-index

  3. EJNMMI Research

    1 publications · 25 citations

    1

    h-index

  4. Journal of Proteomics & Enzymology

    1 publications · 25 citations

    1

    h-index

  5. Neoplasia

    1 publications · 26 citations

    1

    h-index

1–5